LIGAND PHARMACEUTICALS INC
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for LIGAND PHARMACEUTICALS INC NOTE 0.750% 5/1, CUSIP 53220kaf5.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for LIGAND PHARMACEUTICALS INC NOTE 0.750% 5/1, CUSIP 53220kaf5.